<b>Conclusion:</b> Baseline total tumor SUV<sub>mean</sub> on PSMA PET/CT provides independent prognostic information beyond clinical parameters and may serve as a useful biomarker for patient selection and treatment personalization with <sup>177</sup>Lu-PSMA. The gene discussed is FOLH1; the disease is neoplasm.